Terramed Alliance News Healthy Diet Can’t Hurt, May Help Breast Cancer Patients

Breast cancer is the second leading cause of cancer death in women in the United States, with approximately 180,000 cases diagnosed each year. Researchers continue to evaluate environmental factors, such as diet, that influence the development of breast cancer. Numerous studies have provided a wealth of often-contradictory information about the detrimental and protective factors of different foods. High fruit and vegetable consumption has been associated with a reduced risk for developing at least 10 different cancers. Studies evaluating the influence of diet on breast cancer prognosis have produced inconsistent results.

Researchers from California and Utah assessed a cohort of 1,901 women from the Life After Cancer Epidemiology (LACE) Study who were diagnosed with early-stage breast cancer between 1997 and 2000. Upon entering the study, the women completed a food frequency questionnaire (FFQ). The researchers used the data from the FFQs to identify two dietary patterns among the women: a prudent diet included high intakes of fruits, vegetables, whole grains, and poultry, whereas a Western diet included high intakes of red and processed meats and refined grains. The researchers then evaluated the rates of recurrence, overall death, death from breast cancer, and death from causes other than breast cancer. As of May 2008, there were 268 breast cancer recurrences and 226 deaths, 128 of which were attributed to breast cancer.

» Read more: Terramed Alliance News Healthy Diet Can’t Hurt, May Help Breast Cancer Patients

Related posts

Haverford School lax checks for cancer

Haverford School lax checks for cancer
Evelyn Schwartz, Director of Development of the Abramson Family Cancer Research Institute at Penn Medicine, accepts a $12,000 donation from the Checking for Cancer Foundation.

Read more on Main Line Times

Related posts

Terramed Alliance News Safe To Treat HER2-positive Breast Cancer

Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin)–typically used in combination with chemotherapy. However, a new study by researchers at Fox Chase Cancer Center reports that it may be safe to treat these patients with both Trastuzumab and adjuvant radiation therapy.

The study will be presented at the annual meeting of the American Society for Radiation Oncology (ASTRO).

» Read more: Terramed Alliance News Safe To Treat HER2-positive Breast Cancer

Related posts